The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations

Transplant International

Volumn 25, Issue 5, 2012, Pages 527-536

  Wagner, Doris ^a   Kniepeiss, Daniela ^a   Stiegler, Philipp ^a   Zitta, Sabine ^a   Bradatsch, Andrea ^a   Robatscher, Markus ^a   Müller, Helmut ^a   Meinitzer, Andreas ^a   Fahrleitner Pammer, Astrid ^a   Wirnsberger, Gerhard ^a   Iberer, Florian ^a   Tscheliessnigg, Karlheinz ^a   Reibnegger, Gilbert ^a   Rosenkranz, Alexander R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

chronic kidney disease; CKD EPI equation; Cystatin C; MDRD4; orthotopic liver transplantation; serum creatinine

Indexed keywords

CREATININE; CYSTATIN C; GLUCOSE; INULIN; INULINASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACCURACY; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE REGIMEN; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE OXIDATION; GRAFT RECIPIENT; HEPATITIS; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INULIN CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSION; INULIN; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84859728451     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01449.x     Document Type: Article

References (45)

1. Merion RM,. Current status and future in liver transplantation. Semin Liv Dis Nov 2010; 30: 411.
2. Mells G, Neuberger J,. Long term care of the liver allograft recipient. Semin Liv Dis 2009; 29: 102.
3. Ojo AO, Held PJ, Port FK,. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931.
4. Lynn M, Abero K, Zibari G,. End stage renal disease in liver transplants. Clin Transplant 2001; 15: 66.
5. Fisher NC, Nightingale PG, Gunson BK,. Chronic renal failure following liver transplantation. Transplantation 1998; 66: 59.
6. Razonable RR, Findlay JY, O'Riordan A, et al., Critical care issues in patient after liver transplantation. Liver Transplant 2011; 17: 511.
7. Lamattina JC, Foley DP, Mezrich JD, et al.,. Chronic kidney disease stage progression in liver transplant recipients. Clin J Am Soc Nephrol. 2011; 6: 1851.
8. Wald R, Liangos O, Perianayagam MC, et al., Plasma Cystatin C and acute kidney injury after cardiopulmonary bypass. Clin J Am Soc Nephrol 2010; 5: 1373.
9. Madero M, Sarnak MJ, Stevens LA,. Serum Cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 2006; 15: 610.
10. Stevens LA, Levey AS,. Chronic kidney disease in the elderly-how to assess risk. N Engl J Med 2005; 352: 2122.
11. Stevens LA, Coresh J, Schmid CH, et al., Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 2008; 51: 395.
12. Levey AS, Stevens LA, Schmid CH, et al,. A new equation to estimate glomerular filtration rate. Ann Int Med 2009; 150: 604.
13. National Kidney Foundation. Kidney disease outcomes quality initiative. Clinical practice guidelines for chronic kidney disease: evaluation classification and stratification. Am J Kidney Dis 2002; 39: S1.
14. Levey AS, Coresh J, Greene T, et al., Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Inern Med 2006; 145: 247.
15. Miller WG,. Reporting estimated GFR: a laboratory perspective (Editorial). Am J Kidney Dis 2008; 52: 645.
16. Ekonyan G,. Chronic kidney disease and classification: the quest for refinements. Kidney Int 2007; 72: 1183.
17. Wetzels JF, Kiemeney LA, Swinkels DW,. Age and gender-specific reference values of estimated GFR in Caucasians: the Nujmegen biomedical study. Kidney Int 2007; 72: 632.
18. Boudville N, Salama M, Jeffrey JP, et al., The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients. Nephrol Dial Transplant 2009; 24: 2926.
19. Schold J, Navaneethan S, Jolly St, et al., Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol 2011; 6: 1760.
20. Van den Brand JA, van Boeckel G, Welems H, et al., Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant 2011; 10: 3176.
21. White SL, Polkinghorne KR, Atkins RC, et al., Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: 660.
22. Kniepeiss D, Iberer F, Grasser B, Schaffellner S, Tscheliessnigg KH,. Single center experience with retrograde reperfusion in liver transplantation. Transplant Int 2003; 10: 730.
23. Finney H, Newman DJ, Gruber W,. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43: 1016.
24. Hoek FJ, Kemperman FA, Krediet RT,. A comparison between cystatin C, plasma creatinine and the Cockroft-Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024.
25. Larsson A, Malm J, Grubb A, Hansson LO,. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C levels in mg/L. Scand J Clin Lab Invest 2004; 64: 25.
26. Eriksen BO, Mathisen UD, Melsom T, et al., Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 2010; 78: 1305.
27. Zitta S, Stoschitzky K, Zweiker R, et al., Dynamic renal function testing by compartmental analysis: assessment of renal functional reserve in essential hypertension. Nephrol Dial Transplant 2000; 15: 1162.
28. Uhlig K, Macleod A, Craig J, et al., Grading evidence and recommendations for clinical practice guidelines in nephrology: a positions statement from kidney disease improving global outcomes (KDIGO). Kidney Int 2006; 12: 2058.
29. Kuehnle HF, von Dahl K, Schmidt FH,. Fully enzymatic inulin determination in small volume samples without deproteinization. Nephron 1992; 62: 104.
30. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1.
31. Anavekar NS, McMurray JJ, Velazquez EJ, et al., Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285.
32. Creput C, Blandin F, Deroure B, et al., Long term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transplant 2007; 13: 1004.
33. Bahirwani R, Shaked O, Kurd S, et al., Chronic kidney disease after orthotopic liver transplantation: impact of hepatitis C infection. Transplantation 2001; 91: 1245.
34. Brochner-Mortensen J, Giesse J, Rossing N,. Renal inulin clearance versus total plasma clearance of 51Cr-EDTA. Scand J Clin Lab Invest 1969; 23: 301.
35. Sherman DS, Fish DN, Teitelbaum I,. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003; 41: 269.
36. Huang SH, Macnab JJ, Sontrop JM, et al., Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing. Transl Res 2011; 157: 357.
37. Xirouchakis E, Marelli L, Cholongitas E, et al., Comparison of cystatin C and creatinine-based glomerular filtration rateformulas with 51 Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol 2011; 6: 84.
38. Proulx NL, Akbari A, Garg AX, et al., Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Transplant 2005; 20: 1617.
39. Rognant N, Bacchetta J, Dubourg L, et al., What is the best alternative to inulin clearance to estimate GFR with decompensated alcoholic cirrhosis? Nephrol Dial Transplant 2010; 25: 3569.
40. Schück O, Gottfriedova H, Maly J,. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on cystatin C levels. Liver Transplant 2002; 8: 594.
41. Gerhardt T, Poge U, Stoffel-Wagner B,. Estimation of glomerular filtration rates after orthotopic liver transplantation: evaluation of cystatin C based equations. Liver Transplant 2006; 12: 1667.
42. Samyn M, Cheeseman P, Bevis L, et al., Cystatin C, an easy and reliable marker for the assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transplant 2005; 11: 344.
43. Murata K, Baumann NA, Saenger AK, et al,. Relative performance of MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol 2011; 6: 1963.
44. Horio M, Imai E, Yasuda Y, et al,. Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin clearance. Clin Exp Nephrol 2011; 15: 868.
45. Gerhardt T, Pöge U, Stoffel-Wagner B, et al., Creatinine-based glomerular filtration rate estimation in patients with liver disease: the new chronic kidney disease epidemiology collaboration equation is not better. Eur J Gastroenterol Hepatol 2011; 23: 969.